{
    "605700d294d57fd879000021_1": "MRJP1",
    "5883bce3e56acf5176000003_1": "PeakXus",
    "5883bce3e56acf5176000003_2": "PeakXus",
    "5883bce3e56acf5176000003_3": "Q-nexus",
    "5883bce3e56acf5176000003_4": "Q-nexus",
    "5883bce3e56acf5176000003_5": "PeakXus",
    "58da14178acda34529000011_1": "13",
    "58da14178acda34529000011_2": "13",
    "58da14178acda34529000011_3": "13-15",
    "58da14178acda34529000011_4": "13",
    "58da14178acda34529000011_5": "22",
    "58da14178acda34529000011_6": "13",
    "58da14178acda34529000011_7": "15",
    "58da14178acda34529000011_8": "13",
    "58da14178acda34529000011_9": "13",
    "58da14178acda34529000011_10": "14",
    "58da14178acda34529000011_11": "13",
    "58da14178acda34529000011_12": "13",
    "58da14178acda34529000011_13": "13",
    "5c6ffdd47c78d69471000058_1": "miR-214",
    "5c6ffdd47c78d69471000058_2": "miR-423-5p",
    "5c6ffdd47c78d69471000058_3": "miR-423-5p",
    "5c6ffdd47c78d69471000058_4": "miR-423-5p",
    "53137541e3eabad021000010_1": "OCT4",
    "53137541e3eabad021000010_2": "Oct4",
    "53137541e3eabad021000010_3": "Oct4",
    "53137541e3eabad021000010_4": "c-myc",
    "53137541e3eabad021000010_5": "Oct4",
    "53137541e3eabad021000010_6": "Sox2",
    "53137541e3eabad021000010_7": "OCT4",
    "53137541e3eabad021000010_8": "Oct4",
    "53137541e3eabad021000010_9": "Myc",
    "53137541e3eabad021000010_10": "Klf4",
    "53137541e3eabad021000010_11": "Sox2",
    "53137541e3eabad021000010_12": "Sox2",
    "53137541e3eabad021000010_13": "Oct4",
    "53137541e3eabad021000010_14": "SOX2",
    "53137541e3eabad021000010_15": "Oct4",
    "53137541e3eabad021000010_16": "Sox2",
    "53137541e3eabad021000010_17": "Sox2",
    "53137541e3eabad021000010_18": "Sox2",
    "53137541e3eabad021000010_19": "Sox2",
    "53137541e3eabad021000010_20": "Oct4",
    "53137541e3eabad021000010_21": "Oct4",
    "62755c2a56bf9aee6f000001_1": "breast cancer",
    "62755c2a56bf9aee6f000001_2": "NSCLC",
    "62755c2a56bf9aee6f000001_3": "PDA",
    "62755c2a56bf9aee6f000001_4": "breast cancer",
    "62755c2a56bf9aee6f000001_5": "breast cancer",
    "62755c2a56bf9aee6f000001_6": "breast cancer",
    "60281b1c1cb411341a0000f3_1": "schizophrenia",
    "517a8c918ed59a060a000043_1": "adenovirus",
    "550e9d2cb305b40c5c000001_1": "Age",
    "550e9d2cb305b40c5c000001_2": "Age",
    "550e9d2cb305b40c5c000001_3": "Age",
    "550e9d2cb305b40c5c000001_4": "age",
    "550e9d2cb305b40c5c000001_5": "Age",
    "601f19d11cb411341a000073_1": "Emmanuelle Charpentier",
    "601f19d11cb411341a000073_2": "Emmanuelle Charpentier",
    "601f19d11cb411341a000073_3": "Emmanuelle Charpentier",
    "601f19d11cb411341a000073_4": "Dr. Emmanuelle Charpentier",
    "601f19d11cb411341a000073_5": "Emmanuelle Charpentier",
    "601f19d11cb411341a000073_6": "Emmanuelle Charpentier",
    "601f19d11cb411341a000073_7": "Emmanuelle Charpentier",
    "601f19d11cb411341a000073_8": "Emmanuelle Charpentier",
    "601f19d11cb411341a000073_9": "Jennifer Doudna",
    "601f19d11cb411341a000073_10": "Emmanuelle Charpentier",
    "52eea509c8da89891000000d_1": "KCNQ1",
    "52eea509c8da89891000000d_2": "KCNQ1",
    "52eea509c8da89891000000d_3": "KCNQ1",
    "52eea509c8da89891000000d_4": "HERG",
    "52eea509c8da89891000000d_5": "KCNJ5",
    "52eea509c8da89891000000d_6": "KCNQ1",
    "52eea509c8da89891000000d_7": "human ether-a-go-go-related gene",
    "52eea509c8da89891000000d_8": "KCNQ1",
    "52eea509c8da89891000000d_9": "KCNE1",
    "52eea509c8da89891000000d_10": "KCNQ1",
    "52eea509c8da89891000000d_11": "KVLQT1",
    "52eea509c8da89891000000d_12": "KCNE1",
    "52eea509c8da89891000000d_13": "KVLQT1",
    "52eea509c8da89891000000d_14": "HERG",
    "52eea509c8da89891000000d_15": "KVLQT1",
    "52eea509c8da89891000000d_16": "SCN5A",
    "52eea509c8da89891000000d_17": "KVLQT1",
    "602346eb1cb411341a000090_1": "atezolizumab",
    "602346eb1cb411341a000090_2": "lenvatinib",
    "602346eb1cb411341a000090_3": "atezolizumab",
    "602346eb1cb411341a000090_4": "atezolizumab",
    "602346eb1cb411341a000090_5": "atezolizumab",
    "602346eb1cb411341a000090_6": "atezolizumab",
    "602346eb1cb411341a000090_7": "atezolizumab",
    "602346eb1cb411341a000090_8": "atezolizumab",
    "602346eb1cb411341a000090_9": "atezolizumab",
    "602346eb1cb411341a000090_10": "atezolizumab",
    "602346eb1cb411341a000090_11": "atezolizumab",
    "602346eb1cb411341a000090_12": "atezolizumab",
    "602346eb1cb411341a000090_13": "atezolizumab",
    "602346eb1cb411341a000090_14": "atezolizumab",
    "602346eb1cb411341a000090_15": "atezolizumab",
    "602346eb1cb411341a000090_16": "atezolizumab",
    "602346eb1cb411341a000090_17": "atezolizumab",
    "602346eb1cb411341a000090_18": "bevacizumab",
    "602346eb1cb411341a000090_19": "atezolizumab",
    "602346eb1cb411341a000090_20": "atezolizumab",
    "602346eb1cb411341a000090_21": "atezolizumab",
    "5713b0a51174fb175500000e_1": "X-linked Charcot-Marie-Tooth disease",
    "5713b0a51174fb175500000e_2": "X-linked Charcot-Marie-Tooth disease type 5",
    "5713b0a51174fb175500000e_3": "CMTX5",
    "5713b0a51174fb175500000e_4": "X-linked",
    "5713b0a51174fb175500000e_5": "X-linked Charcot-Marie-Tooth disease",
    "5713b0a51174fb175500000e_6": "X-linked",
    "5713b0a51174fb175500000e_7": "X-linked",
    "5713b0a51174fb175500000e_8": "X-linked Charcot-Marie-Tooth disease type 5",
    "5713b0a51174fb175500000e_9": "X-linked Charcot-Marie-Tooth disease type 5",
    "5713b0a51174fb175500000e_10": "X-linked",
    "5713b0a51174fb175500000e_11": "Arts syndrome",
    "5713b0a51174fb175500000e_12": "X-linked Charcot-Marie-Tooth disease",
    "5543a1b2ee40ea110c000001_1": "chloroplasts",
    "58e0035f6fddd3e83e000009_1": "microtubules",
    "5a86ebf2faa1ab7d2e000038_1": "CLOCK",
    "5a86ebf2faa1ab7d2e000038_2": "CLOCK",
    "5a86ebf2faa1ab7d2e000038_3": "CLOCK",
    "5a86ebf2faa1ab7d2e000038_4": "CLOCK",
    "5a86ebf2faa1ab7d2e000038_5": "CLOCK",
    "5a86ebf2faa1ab7d2e000038_6": "CLOCK",
    "5a86ebf2faa1ab7d2e000038_7": "CLOCK",
    "5a86ebf2faa1ab7d2e000038_8": "CLOCK",
    "5a86ebf2faa1ab7d2e000038_9": "CLOCK",
    "5a86ebf2faa1ab7d2e000038_10": "CLOCK",
    "5a86ebf2faa1ab7d2e000038_11": "CLOCK",
    "5a86ebf2faa1ab7d2e000038_12": "clock",
    "5a86ebf2faa1ab7d2e000038_13": "clock",
    "5a86ebf2faa1ab7d2e000038_14": "clock",
    "5a86ebf2faa1ab7d2e000038_15": "clock",
    "5a86ebf2faa1ab7d2e000038_16": "clock",
    "5324cf139b2d7acc7e00001f_1": "depression",
    "5324cf139b2d7acc7e00001f_2": "Premature ejaculation",
    "5324cf139b2d7acc7e00001f_3": "dapoxetine",
    "5324cf139b2d7acc7e00001f_4": "fibromyalgia syndrome. Systematic review, meta-analysis and guideline].",
    "5324cf139b2d7acc7e00001f_5": "depression",
    "5324cf139b2d7acc7e00001f_6": "hot flashes",
    "5324cf139b2d7acc7e00001f_7": "duloxetine is a possible alternative treatment of postprostatectomy established stress urinary incontinence",
    "5324cf139b2d7acc7e00001f_8": "fibromyalgia",
    "5324cf139b2d7acc7e00001f_9": "antidepressants, gabapentine",
    "5324cf139b2d7acc7e00001f_10": "erectile dysfunction",
    "5324cf139b2d7acc7e00001f_11": "dapoxetine",
    "5324cf139b2d7acc7e00001f_12": "oral selective serotonin reuptake inhibitors (SSRIs",
    "5324cf139b2d7acc7e00001f_13": "Duloxetine",
    "5324cf139b2d7acc7e00001f_14": "trazodone",
    "5c5f03371a4c55d80b000009_1": "PARL",
    "5c5f03371a4c55d80b000009_2": "Pcp1",
    "5c5f03371a4c55d80b000009_3": "GlpG",
    "5c5f03371a4c55d80b000009_4": "GlpG",
    "5c72b6be7c78d69471000072_1": "phosphoinositide 3-kinase-\u03b4",
    "5c72b6be7c78d69471000072_2": "phosphoinositide-3 kinase \u03b4",
    "5548da00f35db7552600000b_1": "myosins-Ibeta, -VI, and -VIIa",
    "5548da00f35db7552600000b_2": "myosins-Ibeta, -VI, and -VIIa",
    "5548da00f35db7552600000b_3": "myosin VI",
    "5548da00f35db7552600000b_4": "myosins-Ibeta, -VI, and -VIIa",
    "5548da00f35db7552600000b_5": "myosins-Ibeta, -VI, and -VIIa",
    "6278dd4c56bf9aee6f000011_1": "MD STARnet",
    "6278dd4c56bf9aee6f000011_2": "ImagingDMD",
    "6278dd4c56bf9aee6f000011_3": "GSE38417",
    "6278dd4c56bf9aee6f000011_4": "MD STARnet",
    "6278dd4c56bf9aee6f000011_5": "Remudy",
    "6278dd4c56bf9aee6f000011_6": "Remudy",
    "6278dd4c56bf9aee6f000011_7": "GSE38417 of DMD was obtained from the Gene Expression Omnibus",
    "6278dd4c56bf9aee6f000011_8": "MD STARnet",
    "6278dd4c56bf9aee6f000011_9": "patient registry",
    "6278dd4c56bf9aee6f000011_10": "Developmental Delay",
    "6278dd4c56bf9aee6f000011_11": "MD STARnet",
    "6278dd4c56bf9aee6f000011_12": "Gene Expression Omnibus",
    "6278dd4c56bf9aee6f000011_13": "drisapersen",
    "6278dd4c56bf9aee6f000011_14": "PRO051-02",
    "5a8afbf2fcd1d6a10c00001c_1": "femur",
    "621218fc3a8413c653000014_1": "BCMA",
    "58a2fac960087bc10a000009_1": "hepatotoxicity",
    "58a2fac960087bc10a000009_2": "hepatotoxicity",
    "58a2fac960087bc10a000009_3": "Nausea",
    "58a2fac960087bc10a000009_4": "diarrhoea",
    "58a2fac960087bc10a000009_5": "nausea",
    "58a2fac960087bc10a000009_6": "hepatotoxicity",
    "5c6e01af7c78d69471000048_1": "CMV infection and disease",
    "5c6e01af7c78d69471000048_2": "CMV infection",
    "5c6e01af7c78d69471000048_3": "CMV infection and disease",
    "5171651e8ed59a060a000009_1": "prostate-specific antigen",
    "5171651e8ed59a060a000009_2": "PSA",
    "626aecc6e764a53204000042_1": "United States Food and Drug Agency",
    "5e31b575fbd6abf43b00004c_1": "sensorineural deafness",
    "5e31b575fbd6abf43b00004c_2": "sensorineural deafness",
    "5e31b575fbd6abf43b00004c_3": "sensorineural deafness",
    "5e31b575fbd6abf43b00004c_4": "sensorineural deafness",
    "5e31b575fbd6abf43b00004c_5": "sensorineural deafness",
    "5e31b575fbd6abf43b00004c_6": "sensorineural deafness",
    "5e31b575fbd6abf43b00004c_7": "sensorineural deafness",
    "5e31b575fbd6abf43b00004c_8": "sensorineural deafness",
    "5e31b575fbd6abf43b00004c_9": "sensorineural deafness",
    "5e31b575fbd6abf43b00004c_10": "sensorineural deafness",
    "5e31b575fbd6abf43b00004c_11": "sensorineural deafness",
    "5e92005c2d3121100d000003_1": "Ebola virus",
    "5e92005c2d3121100d000003_2": "HIV",
    "550312b4e9bde6963400001c_1": "GATA1",
    "550312b4e9bde6963400001c_2": "RPS19",
    "550312b4e9bde6963400001c_3": "RPS19",
    "550312b4e9bde6963400001c_4": "GATA1",
    "550312b4e9bde6963400001c_5": "RPS17",
    "550312b4e9bde6963400001c_6": "RPS19",
    "550312b4e9bde6963400001c_7": "RPS19",
    "550312b4e9bde6963400001c_8": "RPS19",
    "550312b4e9bde6963400001c_9": "RPS19",
    "550312b4e9bde6963400001c_10": "RPS19",
    "550312b4e9bde6963400001c_11": "RPS19",
    "5e46f9683f54159529000010_1": "radiation necrosis",
    "5e46f9683f54159529000010_2": "gliomas",
    "5e46f9683f54159529000010_3": "pneumonitis",
    "5e46f9683f54159529000010_4": "fibrosis",
    "5e46f9683f54159529000010_5": "skin reactions",
    "56bf487def6e394741000011_1": "Aip1",
    "5e52900d6d0a277941000041_1": "protease-activated receptor1&2",
    "5e9208702d3121100d000009_1": "\u03b1 and \u03b2-defensins",
    "5e9208702d3121100d000009_2": "\u03b1- and \u03b2-defensins",
    "5c658a8f7c78d69471000007_1": "diarrhea",
    "532b15ecd6d3ac6a34000014_1": "bortezomib",
    "532b15ecd6d3ac6a34000014_2": "cisplatin",
    "532b15ecd6d3ac6a34000014_3": "pingyangmycin",
    "532b15ecd6d3ac6a34000014_4": "pingyangmycin",
    "532b15ecd6d3ac6a34000014_5": "pingyangmycin",
    "5e80caeb835f4e477700002b_1": "malaria",
    "5e80caeb835f4e477700002b_2": "malaria",
    "5e80caeb835f4e477700002b_3": "systemic lupus erythematosus (SLE",
    "5e80caeb835f4e477700002b_4": "SARS",
    "5a86c938faa1ab7d2e000034_1": "SCFTIR1-IAA6",
    "5a86c938faa1ab7d2e000034_2": "SHY2/IAA3",
    "5a86c938faa1ab7d2e000034_3": "IAA9",
    "5a86c938faa1ab7d2e000034_4": "IAA9",
    "5a86c938faa1ab7d2e000034_5": "IAA9",
    "5a86c938faa1ab7d2e000034_6": "IAA3",
    "5a86c938faa1ab7d2e000034_7": "1 also exhibit wild type phenotypes global gene expression analysis reveals that the molecular phenotypes of auxin treated and untreated light grown seedlings are unaffected in the iaa17",
    "5a86c938faa1ab7d2e000034_8": "tashy2",
    "532c0d7fd6d3ac6a3400001c_1": "LigandScout",
    "532c0d7fd6d3ac6a3400001c_2": "Discovery Studio",
    "532c0d7fd6d3ac6a3400001c_3": "Catalyst",
    "532c0d7fd6d3ac6a3400001c_4": "PharmaGist",
    "532c0d7fd6d3ac6a3400001c_5": "Discovery studio",
    "532c0d7fd6d3ac6a3400001c_6": "Catalyst",
    "532c0d7fd6d3ac6a3400001c_7": "GASP",
    "532c0d7fd6d3ac6a3400001c_8": "Discovery studio",
    "532c0d7fd6d3ac6a3400001c_9": "CATALYST HypoRefine",
    "532c0d7fd6d3ac6a3400001c_10": "catalyst",
    "532c0d7fd6d3ac6a3400001c_11": "HypoGen",
    "532c0d7fd6d3ac6a3400001c_12": "HypoGen",
    "532c0d7fd6d3ac6a3400001c_13": "MOE-package",
    "532c0d7fd6d3ac6a3400001c_14": "Catalyst/HipHop",
    "532c0d7fd6d3ac6a3400001c_15": "Catalyst",
    "532c0d7fd6d3ac6a3400001c_16": "HypoGen",
    "58962ed178275d0c4a000006_1": "sacubitril",
    "58962ed178275d0c4a000006_2": "sacubitril",
    "58962ed178275d0c4a000006_3": "Sacubitril",
    "58962ed178275d0c4a000006_4": "Sacubitril",
    "58962ed178275d0c4a000006_5": "sacubitril",
    "58962ed178275d0c4a000006_6": "Sacubitril",
    "58962ed178275d0c4a000006_7": "sacubitril",
    "58962ed178275d0c4a000006_8": "Sacubitril",
    "58962ed178275d0c4a000006_9": "sacubitril",
    "58962ed178275d0c4a000006_10": "Sacubitril",
    "5e92015b2d3121100d000004_1": "chronic lymphocytic leukemia",
    "5e92015b2d3121100d000004_2": "soluble CD30",
    "5e92015b2d3121100d000004_3": "GALECTIN-3",
    "5333f728d6d3ac6a34000041_1": "na\u00efve Bayes classifier",
    "5333f728d6d3ac6a34000041_2": "Negatome",
    "5333f728d6d3ac6a34000041_3": "Negatome",
    "5333f728d6d3ac6a34000041_4": "Support Vector Machine",
    "5333f728d6d3ac6a34000041_5": "PEWCC",
    "5333f728d6d3ac6a34000041_6": "iPTMClust",
    "5333f728d6d3ac6a34000041_7": "NDComplex",
    "5333f728d6d3ac6a34000041_8": "PROCOMOSS",
    "5333f728d6d3ac6a34000041_9": "metaPIS",
    "5333f728d6d3ac6a34000041_10": "EPOF",
    "5333f728d6d3ac6a34000041_11": "EAGLE",
    "5333f728d6d3ac6a34000041_12": "ClusterONE",
    "5333f728d6d3ac6a34000041_13": "MCL",
    "5333f728d6d3ac6a34000041_14": "HKC",
    "5333f728d6d3ac6a34000041_15": "RRW",
    "5333f728d6d3ac6a34000041_16": "CPM",
    "5333f728d6d3ac6a34000041_17": "PIPE",
    "60321aad1cb411341a000134_1": "cytolysin A",
    "60321aad1cb411341a000134_2": "Streptolysin O",
    "60321aad1cb411341a000134_3": "pneumolysin",
    "60321aad1cb411341a000134_4": "streptolysin O",
    "60321aad1cb411341a000134_5": "leukocidin",
    "56cdf3745795f9a73e000039_1": "mTOR",
    "56cdf3745795f9a73e000039_2": "mTOR",
    "56cdf3745795f9a73e000039_3": "mTOR",
    "56cdf3745795f9a73e000039_4": "mTOR",
    "56cdf3745795f9a73e000039_5": "mTOR",
    "56cdf3745795f9a73e000039_6": "mTOR",
    "5e2f906ffbd6abf43b00002c_1": "oral viscous lidocaine",
    "5e2f906ffbd6abf43b00002c_2": "Benzocaine",
    "5e2f906ffbd6abf43b00002c_3": "Donnatal",
    "5e2f906ffbd6abf43b00002c_4": "antacid",
    "5e2f906ffbd6abf43b00002c_5": "2% viscous lidocaine",
    "5e2f906ffbd6abf43b00002c_6": "antacid",
    "5e2f906ffbd6abf43b00002c_7": "antacid",
    "5e2f906ffbd6abf43b00002c_8": "antacid",
    "5895e9977d9090f353000013_1": "Hypotrichosis",
    "5895e9977d9090f353000013_2": "hypotrichosis",
    "5895e9977d9090f353000013_3": "ectodermal dysplasia",
    "5895e9977d9090f353000013_4": "ectodermal dysplasia",
    "5895e9977d9090f353000013_5": "ectodermal dysplasia",
    "5895e9977d9090f353000013_6": "ectodermal dysplasia",
    "5895e9977d9090f353000013_7": "Ectodermal dysplasia",
    "5895e9977d9090f353000013_8": "ectodermal dysplasia",
    "5895e9977d9090f353000013_9": "ectodermal dysplasia",
    "5895e9977d9090f353000013_10": "ectodermal dysplasia",
    "5895e9977d9090f353000013_11": "ectodermal dysplasia",
    "5895e9977d9090f353000013_12": "Ectodermal dysplasia",
    "5895e9977d9090f353000013_13": "ectodermal dysplasia",
    "56e460d051531f7e33000019_1": "sleep",
    "56e460d051531f7e33000019_2": "breast cancer can suppress Wnt/beta-catenin as",
    "56e460d051531f7e33000019_3": "short circadian period",
    "62008130c9dfcb9c0900001c_1": "Leukocytosis (1 point), Tachycardia (1 point), and age",
    "5e493bc06d0a277941000003_1": "glioblastoma",
    "5e493bc06d0a277941000003_2": "glioblastoma",
    "5e493bc06d0a277941000003_3": "Breast cancer",
    "5e493bc06d0a277941000003_4": "pancreatic cancer",
    "5e493bc06d0a277941000003_5": "pancreatic cancer",
    "601d31df1cb411341a00002e_1": "THOC1",
    "6238a32a3a8413c6530000b9_1": "nausea",
    "6238a32a3a8413c6530000b9_2": "nausea",
    "5c928958ecadf2e73f000017_1": "four-channel single-reaction multiplexing",
    "60314ce01cb411341a00012f_1": "thrombocytopenia",
    "60314ce01cb411341a00012f_2": "Thrombocytopenia",
    "60314ce01cb411341a00012f_3": "thrombocytopenia",
    "60314ce01cb411341a00012f_4": "ascites",
    "60314ce01cb411341a00012f_5": "Thrombocytopenia",
    "60314ce01cb411341a00012f_6": "thrombocytopenia",
    "60314ce01cb411341a00012f_7": "Thrombocytopenia",
    "60314ce01cb411341a00012f_8": "Thrombocytopenia",
    "60314ce01cb411341a00012f_9": "Thrombocytopenia",
    "60314ce01cb411341a00012f_10": "thrombocytopenia",
    "60314ce01cb411341a00012f_11": "thrombocytopenia",
    "60314ce01cb411341a00012f_12": "Thrombocytopenia",
    "60314ce01cb411341a00012f_13": "Thrombocytopenia",
    "60314ce01cb411341a00012f_14": "thrombocytopenia",
    "60314ce01cb411341a00012f_15": "Thrombocytopenia",
    "60314ce01cb411341a00012f_16": "Thrombocytopenia",
    "60314ce01cb411341a00012f_17": "Thrombocytopenia",
    "60314ce01cb411341a00012f_18": "Thrombocytopenia",
    "60314ce01cb411341a00012f_19": "thrombocytopenia",
    "60314ce01cb411341a00012f_20": "Thrombocytopenia",
    "60314ce01cb411341a00012f_21": "Thrombocytopenia",
    "60314ce01cb411341a00012f_22": "Thrombocytopenia",
    "60314ce01cb411341a00012f_23": "Thrombocytopenia",
    "60314ce01cb411341a00012f_24": "Thrombocytopenia",
    "60314ce01cb411341a00012f_25": "thrombocytopenia",
    "60314ce01cb411341a00012f_26": "thrombocytopenia",
    "60314ce01cb411341a00012f_27": "thrombocytopenia",
    "60314ce01cb411341a00012f_28": "thrombocytopenia",
    "60314ce01cb411341a00012f_29": "thrombocytopenia",
    "60314ce01cb411341a00012f_30": "idiopathic multicentric Castleman disease with TAFRO syndrome",
    "60322b501cb411341a000137_1": "LGALS7",
    "60322b501cb411341a000137_2": "COL1A1, SCGB1A1, TAGLN",
    "60322b501cb411341a000137_3": "fibronectin",
    "60322b501cb411341a000137_4": "versican",
    "601ec1fb1cb411341a000061_1": "Alobar",
    "5166f41a298dcd4e5100005b_1": "BIX-01294",
    "5166f41a298dcd4e5100005b_2": "BIX-01294",
    "5166f41a298dcd4e5100005b_3": "BIX-01294",
    "5166f41a298dcd4e5100005b_4": "BIX-01294",
    "5166f41a298dcd4e5100005b_5": "2,4-pyridinedicarboxylic acid",
    "5166f41a298dcd4e5100005b_6": "DZNep",
    "5166f41a298dcd4e5100005b_7": "DZNep",
    "5166f41a298dcd4e5100005b_8": "DZNep",
    "5166f41a298dcd4e5100005b_9": "psammaplin A",
    "5166f41a298dcd4e5100005b_10": "sulforaphane",
    "5166f41a298dcd4e5100005b_11": "5-Aza-2'-deoxycytidine",
    "5166f41a298dcd4e5100005b_12": "trichostatin A",
    "5162c8a8298dcd4e51000047_1": "PARN",
    "5162c8a8298dcd4e51000047_2": "CCR4",
    "5162c8a8298dcd4e51000047_3": "CCR4",
    "5162c8a8298dcd4e51000047_4": "Pop2",
    "5162c8a8298dcd4e51000047_5": "CCR4",
    "5162c8a8298dcd4e51000047_6": "DEDD",
    "5162c8a8298dcd4e51000047_7": "CCR4",
    "5162c8a8298dcd4e51000047_8": "CCR4",
    "5162c8a8298dcd4e51000047_9": "PARN",
    "515db20e298dcd4e51000014_1": "CBT",
    "515db20e298dcd4e51000014_2": "CBT",
    "515db20e298dcd4e51000014_3": "individual",
    "5e3c841148dab47f26000002_1": "multiple sclerosis",
    "5e3c841148dab47f26000002_2": "Alzheimer's disease",
    "5e3c841148dab47f26000002_3": "multiple sclerosis",
    "5e3c841148dab47f26000002_4": "Alzheimer's disease",
    "5e3c841148dab47f26000002_5": "Alzheimer's and Parkinson's diseases",
    "58da5dc58acda34529000016_1": "acute heart failure",
    "58da5dc58acda34529000016_2": "heart failure",
    "58da5dc58acda34529000016_3": "heart failure",
    "58da5dc58acda34529000016_4": "heart failure",
    "58da5dc58acda34529000016_5": "heart failure",
    "58da5dc58acda34529000016_6": "type 1",
    "58da5dc58acda34529000016_7": "acute heart failure",
    "58da5dc58acda34529000016_8": "CRS type 1",
    "5523e47f7b523f2123000004_1": "dsRed",
    "5523e47f7b523f2123000004_2": "green fluorescent protein",
    "5523e47f7b523f2123000004_3": "mCherry",
    "5523e47f7b523f2123000004_4": "yellow fluorescent protein",
    "5523e47f7b523f2123000004_5": "green fluorescent reporter protein",
    "5523e47f7b523f2123000004_6": "green fluorescent protein",
    "5523e47f7b523f2123000004_7": "coral",
    "5523e47f7b523f2123000004_8": "GFP",
    "5523e47f7b523f2123000004_9": "eqFP611",
    "5523e47f7b523f2123000004_10": "beta-phycoerythrin",
    "5523e47f7b523f2123000004_11": "Timer",
    "602823e61cb411341a0000f9_1": "irinotecan",
    "602823e61cb411341a0000f9_2": "capecitabine",
    "602823e61cb411341a0000f9_3": "irinotecan",
    "602823e61cb411341a0000f9_4": "capecitabine",
    "602823e61cb411341a0000f9_5": "irinotecan",
    "602823e61cb411341a0000f9_6": "irinotecan",
    "602823e61cb411341a0000f9_7": "capecitabine",
    "602823e61cb411341a0000f9_8": "irinotecan",
    "602823e61cb411341a0000f9_9": "irinotecan",
    "602823e61cb411341a0000f9_10": "gemcitabine",
    "602823e61cb411341a0000f9_11": "irinotecan",
    "602823e61cb411341a0000f9_12": "fluorouracil",
    "602823e61cb411341a0000f9_13": "irinotecan",
    "602823e61cb411341a0000f9_14": "irinotecan",
    "602823e61cb411341a0000f9_15": "irinotecan",
    "52ecf2dd98d023950500002e_1": "rs7140952",
    "52ecf2dd98d023950500002e_2": "Ala92",
    "54fe09036ad7dcbc12000009_1": "notothenoids",
    "54fe09036ad7dcbc12000009_2": "AFP I",
    "54fe09036ad7dcbc12000009_3": "wild type III thermal hysteresis protein",
    "54fe09036ad7dcbc12000009_4": "-3",
    "60274ec61cb411341a0000e5_1": "vincristine",
    "60274ec61cb411341a0000e5_2": "vincristine",
    "60274ec61cb411341a0000e5_3": "cyclophosphamide",
    "60274ec61cb411341a0000e5_4": "vincristine",
    "60274ec61cb411341a0000e5_5": "mesna",
    "60274ec61cb411341a0000e5_6": "vincristine",
    "60274ec61cb411341a0000e5_7": "vindesine",
    "60274ec61cb411341a0000e5_8": "vindesine",
    "60274ec61cb411341a0000e5_9": "vincristine",
    "60274ec61cb411341a0000e5_10": "Vincristine",
    "60274ec61cb411341a0000e5_11": "vincristine, ifosfamide",
    "60274ec61cb411341a0000e5_12": "vincristine",
    "60274ec61cb411341a0000e5_13": "actinomycin D",
    "60274ec61cb411341a0000e5_14": "Cyclophosphamide",
    "60274ec61cb411341a0000e5_15": "vincristine",
    "60274ec61cb411341a0000e5_16": "dactinomycin",
    "60274ec61cb411341a0000e5_17": "dactinomycin",
    "60274ec61cb411341a0000e5_18": "vincristine",
    "5c851c2675a4a5d219000006_1": "actoxumab",
    "5c851c2675a4a5d219000006_2": "Bezlotoxumab",
    "5c851c2675a4a5d219000006_3": "actoxumab",
    "5c851c2675a4a5d219000006_4": "actoxumab",
    "5c851c2675a4a5d219000006_5": "Bezlotoxumab",
    "5c851c2675a4a5d219000006_6": "Bezlotoxumab",
    "5c851c2675a4a5d219000006_7": "Bezlotoxumab",
    "5c851c2675a4a5d219000006_8": "Bezlotoxumab",
    "58bc666702b8c60953000004_1": "amyotrophic lateral sclerosis",
    "58bc666702b8c60953000004_2": "prions",
    "52e0141498d023950500000e_1": "growth rate deficit",
    "52e0141498d023950500000e_2": "growth retardation",
    "52fa73e82059c6d71c000059_1": "Agrobacterium-mediated",
    "52fa73e82059c6d71c000059_2": "Red/ET recombination",
    "52fa73e82059c6d71c000059_3": "Bacterial artificial chromosomes",
    "52fa73e82059c6d71c000059_4": "cloning the genomes of large DNA viruses as BACs",
    "530cefaaad0bf1360c000002_1": "subgenual cingulate gyrus",
    "530cefaaad0bf1360c000002_2": "medial forebrain bundle",
    "530cefaaad0bf1360c000002_3": "nucleus accumbens",
    "530cefaaad0bf1360c000002_4": "ventral striatum",
    "530cefaaad0bf1360c000002_5": "nucleus accumbens",
    "530cefaaad0bf1360c000002_6": "nucleus accumbens",
    "530cefaaad0bf1360c000002_7": "lateral habenula",
    "530cefaaad0bf1360c000002_8": "nucleus accumbens",
    "530cefaaad0bf1360c000002_9": "nucleus accumbens",
    "530cefaaad0bf1360c000002_10": "ventral caudate nucleus",
    "530cefaaad0bf1360c000002_11": "ventral caudate nucleus",
    "530cefaaad0bf1360c000002_12": "nucleus accumbens",
    "58da2a348acda34529000014_1": "AFP",
    "58da2a348acda34529000014_2": "estriol",
    "58da2a348acda34529000014_3": "Down's syndrome",
    "58da2a348acda34529000014_4": "Down's syndrome",
    "58da2a348acda34529000014_5": "oestriol",
    "58da2a348acda34529000014_6": "Down syndrome",
    "58da2a348acda34529000014_7": "DS",
    "58da2a348acda34529000014_8": "Down syndrome",
    "58da2a348acda34529000014_9": "alpha-fetoprotein",
    "61f52fca882a024a10000003_1": "Joubert syndrome",
    "61f52fca882a024a10000003_2": "Joubert syndrome",
    "61f52fca882a024a10000003_3": "Knobloch syndrome",
    "6027505c1cb411341a0000e6_1": "Thulium laser",
    "6027505c1cb411341a0000e6_2": "Transurethral resection of the prostate (TURP",
    "6027505c1cb411341a0000e6_3": "transurethral resection of the prostate",
    "6027505c1cb411341a0000e6_4": "transurethral resection of the prostate (TURP",
    "6027505c1cb411341a0000e6_5": "Thulium laser",
    "6027505c1cb411341a0000e6_6": "thulium laser transurethral vaporesection of the prostate (ThuVARP) versus transurethral resection of the prostate (TURP",
    "6027505c1cb411341a0000e6_7": "transurethral resection of the prostate",
    "55031270e9bde6963400001a_1": "Fanconi anemia",
    "55031270e9bde6963400001a_2": "Fanconi anemia",
    "55031270e9bde6963400001a_3": "Fanconi anemia",
    "55031270e9bde6963400001a_4": "Fanconi anemia",
    "58839d892305cd7e21000006_1": "growth hormone",
    "58839d892305cd7e21000006_2": "microRNA genes",
    "58839d892305cd7e21000006_3": "microRNA genes",
    "54cf705ff693c3b16b000014_1": "\u03b1v\u03b23",
    "54cf705ff693c3b16b000014_2": "\u03b1v\u03b23",
    "54cf705ff693c3b16b000014_3": "\u03b1v\u03b23",
    "54cf705ff693c3b16b000014_4": "\u03b1v\u03b23",
    "54cf705ff693c3b16b000014_5": "\u03b1v\u03b23",
    "54cf705ff693c3b16b000014_6": "\u03b1v\u03b25",
    "54cf705ff693c3b16b000014_7": "\u03b1v\u03b25",
    "54cf705ff693c3b16b000014_8": "\u03b1v\u03b23",
    "54cf705ff693c3b16b000014_9": "\u03b1v\u03b23",
    "54cf705ff693c3b16b000014_10": "\u03b1V\u03b23",
    "54cf705ff693c3b16b000014_11": "\u03b1v\u03b23",
    "54cf705ff693c3b16b000014_12": "\u03b1v\u03b23",
    "54cf705ff693c3b16b000014_13": "\u03b1v\u03b23",
    "54cf705ff693c3b16b000014_14": "\u03b1v\u03b23",
    "5324cca79b2d7acc7e00001d_1": "obesity",
    "5324cca79b2d7acc7e00001d_2": "dermatology",
    "5324cca79b2d7acc7e00001d_3": "VisualDx",
    "5324cca79b2d7acc7e00001d_4": "myFitnessCompanion\u00ae",
    "5324cca79b2d7acc7e00001d_5": "alcohol-use behavior change or recovery",
    "5324cca79b2d7acc7e00001d_6": "urine flow",
    "587d2700fe8a08052f000001_1": "dbSUPER",
    "587d2700fe8a08052f000001_2": "dbSUPER",
    "587d2700fe8a08052f000001_3": "SEA",
    "587d2700fe8a08052f000001_4": "SEA",
    "587d2700fe8a08052f000001_5": "SEA",
    "587d2700fe8a08052f000001_6": "SEA",
    "587d2700fe8a08052f000001_7": "dbSUPER",
    "587d2700fe8a08052f000001_8": "dbSUPER",
    "587d2700fe8a08052f000001_9": "dbSUPER",
    "587d2700fe8a08052f000001_10": "dbSUPER",
    "571f2b5bbb137a4b0c000010_1": "CCM3",
    "571f2b5bbb137a4b0c000010_2": "CCM1",
    "571f2b5bbb137a4b0c000010_3": "CCM1",
    "571f2b5bbb137a4b0c000010_4": "CCM1",
    "571f2b5bbb137a4b0c000010_5": "CCM1",
    "5547d700f35db75526000007_1": "flaccid dysarthria associated with lower motor neuron impairment",
    "5547d700f35db75526000007_2": "stroke patients with mixed dysarthria",
    "5547d700f35db75526000007_3": "hypokinetic dysarthria, ataxic",
    "5547d700f35db75526000007_4": "ataxic",
    "5547d700f35db75526000007_5": "spastic dysarthria",
    "5547d700f35db75526000007_6": "ataxic",
    "5547d700f35db75526000007_7": "ataxic dysarthria",
    "5547d700f35db75526000007_8": "hypokinetic dysarthria",
    "5547d700f35db75526000007_9": "hypokinetic dysarthria",
    "5547d700f35db75526000007_10": "flaccid",
    "5547d700f35db75526000007_11": "flaccid dysarthria associated with lower motor neuron impairment",
    "5547d700f35db75526000007_12": "flaccid dysarthria associated with lower motor neuron impairment",
    "5547d700f35db75526000007_13": "flaccid dysarthria associated with lower motor neuron impairment",
    "5c61cdd7e842deac67000004_1": "Dolutegravir",
    "61f7d017882a024a1000002f_1": "atenolol",
    "621215ec3a8413c653000012_1": "single-targeted antibodies",
    "621eb93b3a8413c65300005b_1": "VEGF-A",
    "621eb93b3a8413c65300005b_2": "VEGF-A",
    "621eb93b3a8413c65300005b_3": "Tie-2",
    "621eb93b3a8413c65300005b_4": "Ang-2",
    "621eb93b3a8413c65300005b_5": "VEGF",
    "621eb93b3a8413c65300005b_6": "angiopoietin 2 (Ang-2)",
    "621eb93b3a8413c65300005b_7": "VEGF-A",
    "621eb93b3a8413c65300005b_8": "Ang-2",
    "621eb93b3a8413c65300005b_9": "angiopoietin-2",
    "621eb93b3a8413c65300005b_10": "Ang-2",
    "621eb93b3a8413c65300005b_11": "VEGF",
    "621eb93b3a8413c65300005b_12": "VEGF-A",
    "621eb93b3a8413c65300005b_13": "vascular endothelial growth factor-A (VEGF-A)",
    "621eb93b3a8413c65300005b_14": "angiopoietin-2",
    "621eb93b3a8413c65300005b_15": "angiopoietin 2 (Ang-2)",
    "5e4f0a4f6d0a277941000031_1": "gamma",
    "5e4f0a4f6d0a277941000031_2": "alpha",
    "52f88d292059c6d71c000036_1": "growth hormone",
    "52f88d292059c6d71c000036_2": "elevated TSH",
    "52f88d292059c6d71c000036_3": "GHD",
    "52f88d292059c6d71c000036_4": "cortisol",
    "531b1e3cb166e2b80600003b_1": "H3K27me3",
    "531b1e3cb166e2b80600003b_2": "H3K27me3",
    "531b1e3cb166e2b80600003b_3": "H3K36me",
    "531b1e3cb166e2b80600003b_4": "H3K27me3",
    "531b1e3cb166e2b80600003b_5": "K27me3",
    "61f7d535882a024a10000034_1": "KIT",
    "61f7d535882a024a10000034_2": "KIT",
    "61f7d535882a024a10000034_3": "PDGFRA",
    "61f7d535882a024a10000034_4": "KIT",
    "61f7d535882a024a10000034_5": "KIT",
    "61f7d535882a024a10000034_6": "KIT",
    "61f7d535882a024a10000034_7": "KIT",
    "61f7d535882a024a10000034_8": "KIT",
    "61f7d535882a024a10000034_9": "PDGFRA",
    "61f7d535882a024a10000034_10": "platelet-derived growth factor receptor alpha (PDGFRA",
    "61f7d535882a024a10000034_11": "KIT",
    "61f7d535882a024a10000034_12": "PDGFRA",
    "61f7d535882a024a10000034_13": "KIT",
    "61f7d535882a024a10000034_14": "KIT",
    "61f7d535882a024a10000034_15": "KIT",
    "61f7d535882a024a10000034_16": "KIT",
    "61f7d535882a024a10000034_17": "PDGFRA",
    "61f7d535882a024a10000034_18": "KIT",
    "61f7d535882a024a10000034_19": "c-KIT",
    "61f7d535882a024a10000034_20": "KIT",
    "61f7d535882a024a10000034_21": "KIT"
}
